Better than 0% of Healthcare / Pharmaceuticals
Making progress starts at 46. The highest score on SINK is 71.
Cencora, formerly AmerisourceBergen, is a pharmaceutical distributor and services company headquartered in Conshohocken, Pennsylvania, supplying medicines and healthcare products to pharmacies, hospitals and clinics. Incorporated in Delaware in 2001, it had about 51,000 employees and $321.3 billion in FY2025 revenue.
Founded 2001Head office Conshohocken, Pennsylvania, United StatesStaff ~51,000 (FY2025)Revenue $321,333M revenue (FY2025)Website ↗
Cencora's Scope 1 emissions are up 28% on its FY2019 base and its combined Scope 1 and 2 are slightly above it, while its stated Scope 3 grew to 46.1 Mt in FY2025. Renewable electricity is about 20%, it publishes no biodiversity assessment, and 67% of its waste is diverted. It has an SBTi-validated absolute target for FY2032 but has made no net progress, and its UK subsidiary moved its net-zero date from 2030 to 2040.
Cencora scores 33/100 (Below expectations) on SINK's independent climate assessment, scored from public data only. Scores are free. Nobody can pay to change a score, speed it up or hide it. Last verified October 2026.
That places Cencora joint 629th of 1,023 companies scored, and joint 20th of 21 in Healthcare / Pharmaceuticals.
Strongest on Carbon Footprint: Operations and Carbon Footprint: Supply Chain (8/10, 7/10). Weakest on Emissions Trajectory and Nature & Biodiversity Impact (1/10, 2/10).
For each question that lost points, the evidence our public rubric looks for that we didn't find.
What would raise this score
Every question that lost points
A score changes when the evidence does. We use new published evidence at the next rescore. Anyone can send us new evidence, free. How to send it.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale11 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
45% of them were published by Cencora itself; the rest come from independent sources.
“Our Scope 1 emissions for fiscal 2025 were 189,955 MT CO2e.”
“Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements”
“AmerisourceBergen also commits that 82% of its suppliers by spend, covering purchased goods and services, will have science-based targets by FY2027.”
“Our total Scope 3 emissions for FY24 were 40,504,084 MT CO2e.”
“Solar photovoltaic systems help power operations, reducing our carbon footprint while ensuring operational resilience.”
“Cencora, Chiesi Group”
“Oversees the Company's sustainability, corporate responsibility and inclusion strategy, and the Company's related reporting and disclosure practices.”
“Business Roundtable $157,500”
“Bob Mauch is the President and Chief Executive Officer of Cencora, Inc.”
If you believe a source has been misread or a newer version exists, submit a challenge.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Send new evidence, free
Scored low because little is published? Publish what you do and send us the link, free. If it holds up, your score changes, and the change is logged on your page.
How to send evidence →Put your score on your website, free
It shows the current band, sector rank and score, and links to this page, so it changes when the score does.
Track this score
Bidding for a public contract? Check if you need a Carbon Reduction Plan, free →
Free, independent, every source shown. Send it to any buyer who asks about your sustainability.
Cencora is tied at the bottom of the healthcare / pharmaceuticals pack.
Among the 21 major healthcare / pharmaceuticals brands we've scored, Cencora is tied =20th of 21, with 1 other.
The 3 companies in the sector scoring nearest above Cencora.
AbbVie has quantified Scope 1 and 2 emissions with third-party assurance, but Scope 3 remains unmeasured across a global pharmaceutical supply chain.
See the breakdown →CVS Health's Scope 1 and 2 emissions are down 43% since 2019 with reasonable assurance, though Scope 1 rose in 2025, and its Scope 3 total of 26.3 Mt has not fallen steadily.
See the breakdown →Cardinal Health reports Scope 1, 2 and 3 emissions with third-party assurance, but its Scope 1 and 2 are only 17% below FY2019 against a 50% cut targeted for FY2030.
See the breakdown →One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
We'll send one email to confirm. No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
Find your page and claim it, free →Scores are free. Nobody can pay to change a score, speed it up or hide it.